Davidson Sean M, Hausenloy Derek, Duchen Michael R, Yellon Derek M
The Hatter Cardiovascular Institute, University College London Hospitals and Medical School, London, UK.
Int J Biochem Cell Biol. 2006 Mar;38(3):414-9. doi: 10.1016/j.biocel.2005.09.017. Epub 2005 Oct 21.
Post-ischemic interventions that activate phosphatidylinositol-3-OH kinase (PI3K)-Akt or ERK1/2 pro-survival kinases (the so-called "reperfusion injury signalling kinase (RISK) pathway") during the first few minutes of reperfusion protect against lethal reperfusion-induced injury. We have previously shown that insulin protects against reperfusion-induced injury via activation of the PI3K-Akt pathway. In addition, opening of the mitochondrial permeability transition pore (mPTP) at the time of reperfusion is a major determinant of lethal reperfusion-induced injury, and pharmacologically inhibiting it is cardioprotective. In this study, we examined the relationship between the pro-survival kinase pathways and mPTP opening. Specifically, we tested the hypothesis that activation of the pro-survival kinase pathway by insulin protects cardiomyocytes by reducing the probability of mPTP opening upon reperfusion. Laser illumination of the fluorophore, tetramethyl rhodamine methyl ester (TMRM), was used to induce oxidative stress in the preparation of adult rat ventricular cardiomyocytes. Maintained illumination ultimately induces mPTP opening, detected as a global mitochondrial depolarization, followed by ATP depletion and rigor contracture. Insulin significantly delayed mPTP opening by a factor of approximately 1.7-fold (P<0.001). The effect of insulin was prevented by Wortmannin and by LY-294002, inhibitors of the PI3K pathway, by SH-6, a selective inhibitor of Akt, and by L-NAME, an inhibitor of nitric oxide production. The expression of a dominant negative construct of Akt eliminated the effect of insulin in delaying mPTP opening in a cardiac cell line. Furthermore, the overexpression of constitutively active Akt was sufficient to maximally delay mPTP opening. These results indicate that activation of the PI3K-Akt pro-survival kinase pathway inhibits opening of the mPTP, and demonstrate an important link between the survival kinases and the mPTP.
在再灌注的最初几分钟内激活磷脂酰肌醇-3-羟基激酶(PI3K)-Akt或ERK1/2促生存激酶(即所谓的“再灌注损伤信号激酶(RISK)途径”)的缺血后干预措施可预防致死性再灌注诱导的损伤。我们之前已经表明,胰岛素通过激活PI3K-Akt途径预防再灌注诱导的损伤。此外,再灌注时线粒体通透性转换孔(mPTP)的开放是致死性再灌注诱导损伤的主要决定因素,药理学抑制该孔具有心脏保护作用。在本研究中,我们检测了促生存激酶途径与mPTP开放之间的关系。具体而言,我们测试了以下假设:胰岛素激活促生存激酶途径可通过降低再灌注时mPTP开放的概率来保护心肌细胞。利用荧光团四甲基罗丹明甲酯(TMRM)的激光照射在成年大鼠心室心肌细胞制备物中诱导氧化应激。持续照射最终诱导mPTP开放,表现为整体线粒体去极化,随后是ATP耗竭和强直收缩。胰岛素使mPTP开放显著延迟约1.7倍(P<0.001)。渥曼青霉素和LY-294002(PI3K途径抑制剂)、SH-6(Akt选择性抑制剂)以及L-NAME(一氧化氮产生抑制剂)可阻止胰岛素的作用。Akt显性负性构建体的表达消除了胰岛素在心脏细胞系中延迟mPTP开放的作用。此外,组成型活性Akt的过表达足以最大程度地延迟mPTP开放。这些结果表明PI3K-Akt促生存激酶途径的激活抑制mPTP的开放,并证明了生存激酶与mPTP之间的重要联系。